XML 59 R42.htm IDEA: XBRL DOCUMENT v3.3.1.900
Segment Reporting (Tables)
 6 Months Ended
Feb. 29, 2016
Segment Reporting [Abstract]  
Reconciliation of Revenue from Segments to Consolidated
The following table reflects results of operations of the Company’s reportable segments (in millions):

  
Retail Pharmacy
          
  
USA
  
International
  
Pharmaceutical
Wholesale
  
Eliminations
and
Unallocated
 Items
  
Consolidated
 
Three Months Ended February 29, 2016
               
Sales to external customers
 
$
21,500
  
$
3,627
  
$
5,057
  
$
-
  
$
30,184
 
Intersegment sales
  
-
   
62
   
570
   
(632
)
  
-
 
Total Sales
  
21,500
   
3,689
   
5,627
   
(632
)
  
30,184
 
                     
Adjusted Operating Income
 
$
1,632
  
$
335
  
$
155
  
$
(2
)
 
$
2,120
 
                     
Three Months Ended February 28, 2015
                    
Sales to external customers
 
$
21,048
  
$
2,017
  
$
3,508
  
$
-
  
$
26,573
 
Intersegment sales
  
-
   
30
   
357
   
(387
)
  
-
 
Total Sales
  
21,048
   
2,047
   
3,865
   
(387
)
  
26,573
 
                     
Adjusted Operating Income
 
$
1,598
  
$
125
  
$
121
  
$
(4
)
 
$
1,840
 

  
Retail Pharmacy
          
  
USA
  
International
  
Pharmaceutical
Wholesale
  
Eliminations
and
Unallocated
 Items
  
Consolidated
 
Six Months Ended February 29, 2016
               
Sales to external customers
 
$
41,870
  
$
7,086
  
$
10,261
  
$
-
  
$
59,217
 
Intersegment sales
  
-
   
134
   
1,162
   
(1,296
)
  
-
 
Total Sales
  
41,870
   
7,220
   
11,423
   
(1,296
)
  
59,217
 
                     
Adjusted Operating Income
 
$
2,875
  
$
650
  
$
321
  
$
(7
)
 
$
3,839
 
                     
Six Months Ended February 28, 2015
                    
Sales to external customers
 
$
40,602
  
$
2,017
  
$
3,508
  
$
-
  
$
46,127
 
Intersegment sales
  
-
   
30
   
357
   
(387
)
  
-
 
Total Sales
  
40,602
   
2,047
   
3,865
   
(387
)
  
46,127
 
                     
Adjusted Operating Income
 
$
2,716
  
$
125
  
$
121
  
$
(4
)
 
$
2,958
 
Reconciliation of Operating Profit (Loss) from Segments to Consolidated
The following table reconciles adjusted operating income to operating income (in millions):

  
Retail Pharmacy
          
  
USA
  
International
  
Pharmaceutical
Wholesale
  
Eliminations
and
Unallocated
Items
  
Consolidated
 
Three Months Ended February 29, 2016
               
Adjusted Operating Income
 
$
1, 632
  
$
335
  
$
155
  
$
(2
)
 
$
2,120
 
Acquisition-related amortization
                  
(101
)
Cost transformation
                  
(28
)
LIFO provision
                  
(68
)
Acquisition-related costs
                  
(33
)
Asset impairment
                  
(30
)
Operating Income
                 
$
1,860
 
                     
Three Months Ended February  28, 2015
                    
Adjusted Operating Income
 
$
1,598
  
$
125
  
$
121
  
$
(4
)
 
$
1,840
 
(Decrease) increase in fair market value of warrants
                  
(6
)
Acquisition-related amortization
                  
(217
)
LIFO provision
                  
(55
)
Acquisition-related costs
                  
(59
)
Asset impairment
                  
(110
)
Store closures and other optimization costs
                  
(16
)
Operating Income
                 
$
1,377
 

  
Retail Pharmacy
          
  
USA
  
International
  
Pharmaceutical
Wholesale
  
Eliminations
and
Unallocated
Items
  
Consolidated
 
Six Months Ended February 29, 2016
               
Adjusted Operating Income
 
$
2,875
  
$
650
  
$
321
  
$
(7
)
 
$
3,839
 
Acquisition-related amortization
                  
(182
)
Cost transformation
                  
(118
)
LIFO provision
                  
(114
)
Acquisition-related costs
                  
(67
)
Asset impairment
                  
(30
)
Operating Income
                 
$
3,328
 
                     
Six Months Ended February 28, 2015
                    
Adjusted Operating Income
 
$
2,716
  
$
125
  
$
121
  
$
(4
)
 
$
2,958
 
(Decrease) increase in fair market value of warrants
                  
123
 
Acquisition-related amortization
                  
(306
)
LIFO provision
                  
(107
)
Acquisition-related costs
                  
(83
)
Asset impairment
                  
(110
)
Store closures and other optimization costs
                  
(44
)
Operating Income
                 
$
2,431